Insider Trading Alert - NTGR, SCOR And AMRI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 8, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $600.00 to $33,225,000.00.

Highlighted Stocks Traded by Insiders:

Netgear (NTGR) - FREE Research Report

Carter Miller Joycelyn, who is Director at Netgear, sold 4,000 shares at $30.94 on June 8, 2015. Following this transaction, the Director owned 12,332 shares meaning that the stake was reduced by 24.49% with the 4,000-share transaction.

The shares most recently traded at $30.91, down $0.03, or 0.1% since the insider transaction. Historical insider transactions for Netgear go as follows:

  • 4-Week # shares sold: 554
  • 12-Week # shares sold: 1,092
  • 24-Week # shares sold: 1,092

The average volume for Netgear has been 299,700 shares per day over the past 30 days. Netgear has a market cap of $1.1 billion and is part of the technology sector and telecommunications industry. Shares are down 13.04% year-to-date as of the close of trading on Monday.

NETGEAR, Inc. provides networking products to consumers, businesses, and service providers. The company operates in three segments: Retail, Commercial, and Service Provider. The Retail segment offers home networking, home video security, storage, and digital media products. The company has a P/E ratio of 391.0. Currently, there is 1 analyst who rates Netgear a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NTGR - FREE

TheStreet Quant Ratings rates Netgear as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Netgear Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

comScore (SCOR) - FREE Research Report

Fulgoni Gian, who is Chairman Emeritus at comScore, sold 1,000 shares at $57.05 on June 8, 2015. Following this transaction, the Chairman Emeritus owned 152,790 shares meaning that the stake was reduced by 0.65% with the 1,000-share transaction.

The shares most recently traded at $56.18, down $0.87, or 1.54% since the insider transaction. Historical insider transactions for comScore go as follows:

  • 4-Week # shares sold: 88,332
  • 12-Week # shares sold: 144,332
  • 24-Week # shares sold: 254,819

The average volume for comScore has been 264,300 shares per day over the past 30 days. comScore has a market cap of $2.3 billion and is part of the services sector and diversified services industry. Shares are up 21.65% year-to-date as of the close of trading on Monday.

comScore, Inc. provides digital media analytics products and services for content publishers, advertisers, advertising agencies, and network operators primarily in the United States, Canada, Europe, Latin America, and Asia. Currently, there are 5 analysts who rate comScore a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCOR - FREE

TheStreet Quant Ratings rates comScore as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full comScore Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Albany Molecular Research (AMRI) - FREE Research Report

Marth William S, who is President and CEO at Albany Molecular Research, bought 10,000 shares at $19.98 on June 8, 2015. Following this transaction, the President and CEO owned 447,214 shares meaning that the stake was boosted by 2.29% with the 10,000-share transaction.

The shares most recently traded at $19.57, down $0.41, or 2.1% since the insider transaction. Historical insider transactions for Albany Molecular Research go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 2,500
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 86,000
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 208,785

The average volume for Albany Molecular Research has been 450,400 shares per day over the past 30 days. Albany Molecular Research has a market cap of $664.7 million and is part of the health care sector and drugs industry. Shares are up 23.28% year-to-date as of the close of trading on Monday.

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. Currently, there are 2 analysts who rate Albany Molecular Research a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMRI - FREE

TheStreet Quant Ratings rates Albany Molecular Research as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Albany Molecular Research Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Falls Sharply as Wall Street Weighs Trump's New Trade Threats

Dow Falls Sharply as Wall Street Weighs Trump's New Trade Threats

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Intel Gets a Downgrade Following CEO Resignation

Intel Gets a Downgrade Following CEO Resignation

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Ford and General Motors 'Notably Vulnerable' to Trade War: Moody's

Ford and General Motors 'Notably Vulnerable' to Trade War: Moody's